Verition Fund Management LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1454027
GREENWICH, CT
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,908,117
+$2,828,236 QoQ
Shares Held
40,988
+42.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#180
of 768 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $29,871,201 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
40,988 | $6,908,117 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
250,000 | $6,152,500 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
500,000 | $4,915,000 | |
| 4 | LQDA |
Liquidia Corp
|
45,233 | $3,606,427 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
97,363 | $3,375,575 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,675 | $1,991,225 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
15,000 | $1,664,100 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,500 | $479,625 |
All Filings in NBIX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,908,117 | 40,988 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $4,079,881 | 28,766 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,428,915 | 38,673 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,045,060 | 48,095 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,990,357 | 17,996 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,459,867 | 10,695 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $959,206 | 8,325 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $579,539 | 4,202 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $249,948 | 1,897 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,576,387 | 40,679 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,191,823 | 44,452 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,041,065 | 69,562 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $569,251 | 4,766 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $302,061 | 2,844 | Shares | Sole | 2023-01-18 | |
| 2022-06-30 | $369,449 | 3,790 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $9,706,312 | 103,534 | Shares | Sole | 2022-06-02 | |
| 2021-06-30 | $4,159,262 | 42,738 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $623,858 | 6,415 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $10,003,672 | 104,368 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $494,743 | 5,145 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $317,444 | 2,602 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||